
Sign up to save your podcasts
Or
Is it time to buy JAGX? The company has an average price target of $14. Over the last month it has fallen 43.39% so it seems investors are less bullish about the stock than before. That’s all fine and dandy but for people first time hearing about this stock, can they make a quick buck with it? Let’s find out.
Welcome to Money Talk Sundayz. Click that thumbs up button below to check in. Share and subscribe if JAGX is something you’re interested in. Let’s rap Jaguar Health.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.
The stock closed yesterday at 2.05. Today it opened at 2.06 and is currently at 2.10. In the last 52 weeks JAGX was a low as 0.56 and as high as 13.41 with an average 100 day trading volume of 2,607,031.
Personally, I just came across this stock the other day while looking up something else. I figured I’d talk about it with you guys, bros nation, since at the heart, the core of this podcast, it’s about how two brothers play the market.
I’m intrigued about this stock mostly because of the low buy-in opportunity. After infusing thousands of my personal dollars into these market ventures, I’m shifting towards no longer having to use my dollars but rather the profits from swing and options trades to continue building my portfolio. Like they say, make your money make money.
Now, JAGX is set to release their earnings on 11/11/2021. During their last earnings release the company posted EPS of $-1.14.
Now as far as the charts are concerned, JAGX is down 27.42% over the last 30 days losing 0.7947 cents a share. Over the last 3 months, it is down 57.10% losing 2.77 per share. But again over the last year it is up 107.21% however it is trending downwards.
Based upon the chart patterns I’m seeing that it has more falling to do before we see another resurgence in price. By how much more I can’t say but I would ballpark it falling back down to 1.50. What I would do at this moment would be to add it to my watchlist and set alerts for a rapid rise as well as an alert for when it hits my expected floor. Once it bottoms out I’ll then hop in.
My recommendation is swinging this sucker the long way.
Is it time to buy JAGX? The company has an average price target of $14. Over the last month it has fallen 43.39% so it seems investors are less bullish about the stock than before. That’s all fine and dandy but for people first time hearing about this stock, can they make a quick buck with it? Let’s find out.
Welcome to Money Talk Sundayz. Click that thumbs up button below to check in. Share and subscribe if JAGX is something you’re interested in. Let’s rap Jaguar Health.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.
The stock closed yesterday at 2.05. Today it opened at 2.06 and is currently at 2.10. In the last 52 weeks JAGX was a low as 0.56 and as high as 13.41 with an average 100 day trading volume of 2,607,031.
Personally, I just came across this stock the other day while looking up something else. I figured I’d talk about it with you guys, bros nation, since at the heart, the core of this podcast, it’s about how two brothers play the market.
I’m intrigued about this stock mostly because of the low buy-in opportunity. After infusing thousands of my personal dollars into these market ventures, I’m shifting towards no longer having to use my dollars but rather the profits from swing and options trades to continue building my portfolio. Like they say, make your money make money.
Now, JAGX is set to release their earnings on 11/11/2021. During their last earnings release the company posted EPS of $-1.14.
Now as far as the charts are concerned, JAGX is down 27.42% over the last 30 days losing 0.7947 cents a share. Over the last 3 months, it is down 57.10% losing 2.77 per share. But again over the last year it is up 107.21% however it is trending downwards.
Based upon the chart patterns I’m seeing that it has more falling to do before we see another resurgence in price. By how much more I can’t say but I would ballpark it falling back down to 1.50. What I would do at this moment would be to add it to my watchlist and set alerts for a rapid rise as well as an alert for when it hits my expected floor. Once it bottoms out I’ll then hop in.
My recommendation is swinging this sucker the long way.